Literature DB >> 24778038

Levonorgestrel-impregnated Intrauterine device reduces occurrence of hyperplastic polyps: a population-based follow-up cohort study.

Marit Arnes1, Bodil Hvingel, Anne Orbo.   

Abstract

BACKGROUND: The main objective was to investigate if occurrence of hyperplastic polyps was reduced by use of the levonorgestrel-impregnated intrauterine system (LNG-IUS, Mirena®; Bayer) and if the LNG-IUS was more effective compared to oral medroxyprogesterone acetate (MPA) or observation-only. PATIENTS AND METHODS: Patients (N=59) with hyperplastic polyps were given LNG-IUS, 10 mg oral MPA taken 10 days per cycle, or had observation-only for six months. Diagnosis of histological specimens was performed by light microscopy according to the WHO classification and D-score prior to and after six months therapy.
RESULTS: No polyps were found in women treated with LNG-IUS (18/18). Five women treated with cyclic MPA (5/20, 25%) and two (2/21, 9%) with observation had normal endometrium without polyps after six months.
CONCLUSION: No former study has shown that LNG-IUS is effective at reducing the occurrence of hyperplastic endometrial polyps. The effect is superior to that of oral progestin and observation-only.

Entities:  

Keywords:  Hyperplastic endometrial polyps; intrauterine device; levonorgestrel; progestin therapy

Mesh:

Substances:

Year:  2014        PMID: 24778038

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Levonorgestrel Inhibits Human Endometrial Cell Proliferation through the Upregulation of Gap Junctional Intercellular Communication via the Nuclear Translocation of Ser255 Phosphorylated Cx43.

Authors:  Xiaomiao Zhao; Xueliang Tang; Tingting Ma; Miao Ding; Lijuan Bian; Dongmei Chen; Yangzhi Li; Liangan Wang; Yanyan Zhuang; Meiqing Xie; Dongzi Yang
Journal:  Biomed Res Int       Date:  2015-06-16       Impact factor: 3.411

2.  Use of a frameless LNG-IUS as conservative treatment for a pre-malignant uterine polyp in a premenopausal woman - a case report.

Authors:  D Janssens; G Verbeeck; D Wildemeersch
Journal:  Facts Views Vis Obgyn       Date:  2015-12-28

3.  The risk of using intrauterine devices to benign reproductive system conditions in postmenopausal women: A case control study.

Authors:  Xiaohua Zhang; Liping Xiao; Haoping Zhu; Linan Cheng
Journal:  J Res Med Sci       Date:  2016-03-15       Impact factor: 1.852

Review 4.  Association of Hormonal Contraceptive Use With Adverse Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies.

Authors:  Sharmila Brabaharan; Sajesh K Veettil; Jennifer E Kaiser; Vrosha Rau Raja Rao; Rujira Wattanayingcharoenchai; Marikannan Maharajan; Putsarat Insin; Pattarawalai Talungchit; Thunyarat Anothaisintawee; Ammarin Thakkinstian; Nathorn Chaiyakunapruk
Journal:  JAMA Netw Open       Date:  2022-01-04

5.  Post hysteroscopic progesterone hormone therapy in the treatment of endometrial polyps.

Authors:  Fangfang Li; Shuangyan Wei; Shuye Yang; Zhiqiang Liu; Fangfang Nan
Journal:  Pak J Med Sci       Date:  2018 Sep-Oct       Impact factor: 1.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.